Sub‑Management Agreement Between Credit Suisse and New Leaf Venture Partners Governs Sprout Capital Healthcare Investments

Summary

Sub‑Management Agreement Between Credit Suisse and New Leaf Venture Partners Governs Sprout Capital Healthcare Investments The passage details a routine private‑equity sub‑management arrangement and fee structure for a niche healthcare technology portfolio. It mentions only corporate entities (Credit Suisse, New Leaf Venture Partners) and does not link any high‑ranking officials, political figures, or controversial financial flows. While it provides specific dates and dollar amounts that could be useful for a financial‑industry audit, there is no indication of misconduct, foreign influence, or public‑interest controversy. Key insights: Credit Suisse entered a Sub‑Management Agreement with New Leaf Venture Partners for Sprout Capital VI, VII, and IX.; Management fees were paid to the Management Company for healthcare portfolio services, but have now ceased.; As of March 31, 2014, Sprout Capital IX held six active healthcare tech companies worth $68 million.